1. IQGAP1 in Podosomes/Invadosomes Is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status
   Deborah Rotoli et al, 2017, IJMS CrossRef
2. Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition
   Diana Matias et al, 2017, Cell Oncol. CrossRef
3. Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory
   Dongya Jia et al, 2017, Cancers CrossRef
4. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication
   Yasuo IWADATE, 2017, Neurol. Med. Chir.(Tokyo) CrossRef
5. Developmentally regulated signaling pathways in glioma invasion.
   Shwetal Mehta et al, 2018, Cell Mol Life Sci CrossRef
6. Kinin-B1 Receptor Stimulation Promotes Invasion and is Involved in Cell-Cell Interaction of Co-Cultured Glioblastoma and Mesenchymal Stem Cells
   Mona N. Oliveira et al, 2018, Sci Rep CrossRef
7. Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response
   Carlos Gustavo Garcia et al, 2018, Mol Neurobiol CrossRef
8. New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells
   Yoichiro Kawamura et al, 2018, Cell Biol Toxicol CrossRef
9. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial–Mesenchymal Transition
   Zhaotao Wang et al, 2018, Neurochem Res CrossRef
10. PAQR3 inhibits the proliferation, migration and invasion in human glioma cells
    Shi-lei Tang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
11. Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
    Michele Patrizii et al, 2018, Front. Oncol. CrossRef
12. Mesenchymal stromal cell engagement in cancer cell epithelial to mesenchymal transition
    Drenka Trivanović et al, 2017, Dev. Dyn. CrossRef
13. Glioma infiltration and extracellular matrix: key players and modulators
    Valéria Pereira Ferrer et al, 2018, Glia CrossRef
14. Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach
    Melanie Mettang et al, 2018, Sci Rep CrossRef
15. Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance
    Ha Nguyen et al, 2018, IJMS CrossRef
16. Genetically engineered cerebral organoids model brain tumor formation
    Shan Bian et al, 2018, Nat Methods CrossRef
17. Current natural therapies in the treatment against glioblastoma
    José Ignacio Erices et al, 2018, Phytotherapy Research CrossRef
18. Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo
    Davalyn Powell et al, 2018, Sci Rep CrossRef
19. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Jin Zhang et al, 2018, J Exp Clin Cancer Res CrossRef
20. Integrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cell-to-cell adhesion heterogeneity
    M.-E. Oraiopoulou et al, 2018, Sci Rep CrossRef
21. Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation
    Gabriele Riva et al, 2018, Genes CrossRef
22. The Microenvironment in Glioma Invasion
    Mitsutoshi Nakada et al, 2018, Jpn J Neurosurg CrossRef
23. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.
    Anushka Dongre et al, 2019, Nat Rev Mol Cell Biol CrossRef
24. Non-Coding RNAs in Glioma.
    Ryte Rynkeviciene et al, 2018, Cancers (Basel) CrossRef
25. Circulating tumor stem cells and glioblastoma: A review
    Bede van Schaijik et al, 2019, Journal of Clinical Neuroscience CrossRef
26. Extracellular Adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under Hypoxia
    Ángelo Torres et al, 2019, Cancer Letters CrossRef
27. TGF-β-SNAIL axis induces Müller glial-mesenchymal transition in the pathogenesis of idiopathic epiretinal membrane
    Atsuhiro Kanda et al, 2019, Sci Rep CrossRef
28. 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics
    Marcel Alexander Heinrich et al, 2019, Adv. Mater. CrossRef
29. Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models
    Shinichi Esaki et al, 2017, Int. J. Cancer CrossRef
30. MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial–mesenchymal transitions of human glioma cells
    Zhixiao Li et al, 2019, Biosci. Rep. CrossRef
31. MGSEA – a multivariate Gene set enrichment analysis
    Khong-Loon Tiong et al, 2019, BMC Bioinformatics CrossRef
32. Combined treatment with 2′-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness
    Hyewon Jeong et al, 2019, J Neurooncol CrossRef
33. Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
    Junhui Hu et al, 2019, Stem Cells International CrossRef
34. SUMOylation in Glioblastoma: A Novel Therapeutic Target
    Brandon M. Fox et al, 2019, IJMS CrossRef
35. Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas
    Satoru Komaki et al, 2019 CrossRef
36. Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling
    Yang Song et al, 2019, BioMed Research International CrossRef
37. Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management
    Y. Rajesh et al, 2019, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
38. Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation
    Jiejing Li et al, 2017, Sci Rep CrossRef
39. Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage
    G Corda et al, 2017, Oncogenesis CrossRef
40. Loss of cell-matrix contact increases hypoxia-inducible factor-dependent transcriptional activity in glioma cells
    Gabriele D. Maurer et al, 2019, Biochemical and Biophysical Research Communications CrossRef
41. Layilin enhances the invasive ability of malignant glioma cells via SNAI1 signaling
    Tomohiro Kaji et al, 2019, Brain Research CrossRef
42. The biology and mathematical modelling of glioma invasion: a review
    J. C. L. Alfonso et al, 2017, J. R. Soc. Interface CrossRef
43. Kinins in Glioblastoma Microenvironment
    Mona N. Oliveira et al, 2019, Cancer Microenvironment CrossRef
44. Dissecting and rebuilding the glioblastoma microenvironment with engineered materials
    Kayla J. Wolf et al, 2019, Nat Rev Mater CrossRef
45. Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
    null Kim et al, 2019, Cancers CrossRef
46. Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells
    Kui Wang et al, 2016, Adv. Healthcare Mater. CrossRef
47. TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression
    Svetlana A. Mikheeva et al, 2019, Cancers CrossRef
48. Integrating the glioblastoma microenvironment into engineered experimental models
    Weikun Xiao et al, 2017, Future Science OA CrossRef
49. Angiogenesis inhibitors in tackling recurrent glioblastoma.
    Thomas Hundsberger et al, 2017, Expert Rev Anticancer Ther CrossRef
50. The Unwanted Cell Migration in the Brain: Glioma Metastasis
    Xue Tao Qi et al, 2017, Neurochem Res CrossRef
51. Carboxypeptidase E transmits its anti-migratory function in glioma cells via transcriptional regulation of cell architecture and motility regulating factors
    Angela Armento et al, 2017 CrossRef
52. null
    Federica Caponnetto et al, 2017 CrossRef
53. Defining Protein Pattern Differences Among Molecular Subtypes of Diffuse Gliomas Using Mass Spectrometry
    Ugljesa Djuric et al, 2019, Mol Cell Proteomics CrossRef
54. Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
    Myung-Giun Noh et al, 2017, BMC Cancer CrossRef
55. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma
    Chitrangda Srivastava et al, 2017, Int. J. Cancer CrossRef
56. Brain Malignancies: Cancer Cell Trafficking in and out of the Niches
    Tamara T. Lah et al, 2019, Seminars in Cancer Biology CrossRef
57. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial–mesenchymal transition
    Li Zhang et al, 2017 CrossRef
58. Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in Glioblastoma
    Yasuo Takashima et al, 2019, Cells CrossRef
59. Identification of Dysregulated Competitive Endogenous RNA Networks Driven by Copy Number Variations in Malignant Gliomas
    Jinyuan Xu et al, 2019, Front. Genet. CrossRef
60. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
    Jong Hyun Lee et al, 2019, Pharmacological Research CrossRef
61. 11 Long noncoding RNA UCA1 functions as miR‐135a sponge to promote the epithelial to mesenchymal transition in glioma
    Zhi‐guo Li et al, 2019, J Cell Biochem CrossRef
62. The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
    Xiaobo Li et al, 2019, Cells CrossRef
63. Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment
    Dorcas A. Annan et al, 2019, Cell Commun Signal CrossRef
64. Expression pattern of EEF1A2 in brain tumors: Histological analysis and functional role as a promoter of EMT
    Md. Khurshidul Hassan et al, 2020, Life Sciences CrossRef
65. Matrix protease production, epithelial-to-mesenchymal transition marker expression and invasion of glioblastoma cells in response to osmotic or hydrostatic pressure
    Wenjun Pu et al, 2020, Sci Rep CrossRef
66. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT)
    Guodong Zhang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
67. null
    ANGELA ARMENTO et al, 2017 CrossRef
68. Targeting of Endoplasmic Reticulum (ER) Stress in Gliomas
    Mariam Markouli et al, 2020, Pharmacological Research CrossRef
69. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme
    Marek Mazurek et al, 2020, IJMS CrossRef
70. The limitations of targeting MEK signalling in Glioblastoma therapy.
    Mike-andrew Westhoff, 0 CrossRef
71. Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas
    Sasha J. Beyer et al, 2018, Oncotarget CrossRef
72. Pericytes/vessel-associated mural cells (VAMCs) are the major source of key epithelial-mesenchymal transition (EMT) factors SLUG and TWIST in human glioma
    Lisa Mäder et al, 2018, Oncotarget CrossRef
73. Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model
    Ninh B. Doan et al, 2018, Oncotarget CrossRef
74. CBX7 negatively regulates migration and invasion in glioma via Wnt/β-catenin pathway inactivation
    Zhongyuan Bao et al, 2017, Oncotarget CrossRef
75. Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
    Julia Onken et al, 2017, Oncotarget CrossRef
76. Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
    Richard E Kast et al, 2017, Oncotarget CrossRef
77. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling
    Maciej Pudełek et al, 2020, IJMS CrossRef
78. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review)
    Igor Bryukhovetskiy et al, 2018, Int J Mol Med CrossRef
79. Tubastatin�A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells
    Alejandro Urdiciain et al, 2019, Int J Oncol CrossRef
80. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway
    Wenbo Xiao et al, 2020, Int J Mol Med CrossRef
81. STC1 regulates glioblastoma migration and invasion via the TGF‑β/SMAD4 signaling pathway
    Yan Xiong et al, 2019, Mol Med Report CrossRef
82. Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas
    Eui Hyun Kim et al, 2020, Cells CrossRef
83. Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy
    David S Kim, 2020, Future Oncology CrossRef
84. Epithelioid glioblastoma with microglia features: potential for novel therapy
    Nami Nakagomi et al, 2020, Brain Pathol CrossRef
85. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis
    Tayebeh Rezaei et al, 2020, European Journal of Pharmacology CrossRef
86. The impact of autophagy during the development and survival of glioblastoma
    Joanne E. Simpson et al, 2020, Open Biol. CrossRef
87. The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: What do we know so far?
    Antonela S Asad et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
88. Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial-Mesenchymal Transition (EMT).
    Yu Xiong et al, 2020, Onco Targets Ther CrossRef
89. Molecular and Cellular Mechanisms of Human Astrocytoma Progression: Advances in Knowledge to Reach Therapeutic Horizons
    Sergio Comincini, 2020, Cells CrossRef
90. Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies
    Maria Peleli et al, 2020, IJMS CrossRef
91. Anticancer Effects of AKBA on Glioblastoma Cancer Cells Through Modulating TWIST1 and FOXM1 Expression Levels
    Laleh Ranjbaran et al, 2020, Iran J Sci Technol Trans Sci CrossRef
92. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence
    Vidya P. Nimbalkar et al, 2021, J Neurooncol CrossRef
93. Hallmarks of glioblastoma: a systematic review.
    Dorte Schou Nørøxe et al, 0 CrossRef
94. Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
    Manali Tilak et al, 2021, IJMS CrossRef
95. P53/miR-154 Pathway Regulates the Epithelial-Mesenchymal Transition in Glioblastoma Multiforme Cells by Targeting TCF12
    Gang Zhu et al, 2021, NDT CrossRef
96. Rodent Models to Analyze the Glioma Microenvironment
    Susann Hetze et al, 2021, ASN Neuro CrossRef
97. Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells
    Carlotta Pucci et al, 2021, Acta Biomaterialia CrossRef
98. Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy
    Kimmy Tran et al, 2021, Neurochemistry International CrossRef
99. Reboot: a straightforward approach to identify genes and splicing isoforms associated with cancer patient prognosis
    Felipe R C dos Santos et al, 2021 CrossRef
100. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
     Manasa Kalya et al, 2021, Front. Genet. CrossRef
101. Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
     Christopher Dardis et al, 2021, BMC Neurol CrossRef
102. null
     Victoria J. Horak et al, 2021 CrossRef
103. null
     Kirsten Ludwig et al, 2021 CrossRef
104. null
     Kshama Gupta, 2021 CrossRef
105. null
     Marina Nikolopoulos et al, 2021 CrossRef
106. Multimodal Role of PACAP in Glioblastoma
     Agata Grazia D’Amico et al, 2021, Brain Sciences CrossRef
107. Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress
     Tom M. Thomas et al, 2021, Mol Cancer Res CrossRef
108. Effect of PACAP on Hypoxia-Induced Angiogenesis and Epithelial-Mesenchymal Transition in Glioblastoma.
     Grazia Maugeri et al, 2021, Biomedicines CrossRef
109. Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival
     Chiara Moriconi et al, 2021, Front. Oncol. CrossRef
110. Epithelial to mesenchymal transition (EMT) of human stem cell-derived retinal pigment epithelium shares commonalities with malignancy-associated EMT: a proteomic analysis
     Srinivasa R. Sripathi et al, 2021, Molecular & Cellular Proteomics CrossRef
111. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
     Kebing Huang et al, 2021, Front. Oncol. CrossRef
112. Single-cell tracking reveals super-spreading brain cancer cells with high persistence
     Aimilia Nousi et al, 2021, Biochemistry and Biophysics Reports CrossRef
113. Modeling glioblastoma heterogeneity as a dynamic network of cell states
     Ida Larsson et al, 2021, Mol Syst Biol CrossRef
114. Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor
     Chan-Chuan Liu et al, 2021, IJMS CrossRef
115. Combining experiments and in silico modeling to infer the role of adhesion and proliferation on the collective dynamics of cells
     Hygor P. M. Melo et al, 2021, Sci Rep CrossRef
116. TP53 Mutation and Extraneural Metastasis of Glioblastoma
     Xiaoming Zhang et al, 2021 CrossRef
117. null
     Thomas Daubon et al, 2021 CrossRef
118. Transitioning pre-clinical glioblastoma models to clinical settings with biomarkers identified in 3D cell-based models: A systematic scoping review
     Brandon Wee Siang Phon et al, 2022, Biomedicine & Pharmacotherapy CrossRef
119. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
     Seyed Mojtaba Mousavi et al, 2022, Molecular Therapy - Oncolytics CrossRef
120. Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives
     Fidan Seker-Polat et al, 2022, Cancers CrossRef
121. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
     Amir Barzegar Behrooz et al, 2022, IJMS CrossRef
122. MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
     Botle Precious Setlai et al, 2022, Genes CrossRef
123. Molecular Mechanisms and Clinical Challenges of Glioma Invasion
     Tomoya Oishi et al, 2022, Brain Sciences CrossRef
124. Glioblastoma Microenvironment and Cellular Interactions
     Carmen-Bianca Crivii et al, 2022, Cancers CrossRef
125. Tumor Heterogeneity and Molecular Characteristics of Glioblastoma Revealed by Single-Cell RNA-Seq Data Analysis
     Dhanusha Yesudhas et al, 2022, Genes CrossRef
126. Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas
     Yan-Xia Wang et al, 2022, Sig Transduct Target Ther CrossRef
127. Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma
     Sojin Kim et al, 2022, Cell. Mol. Life Sci. CrossRef
128. Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness
     Stefano Ratti et al, 2022, Cell. Mol. Life Sci. CrossRef
129. Tumor Microenvironment in Glioma Invasion
     Sho Tamai et al, 2022, Brain Sciences CrossRef
130. Cellular Model of Malignant Transformation of Primary Human Astrocytes Induced by Deadhesion/Readhesion Cycles
     Roseli da S. Soares et al, 2022, IJMS CrossRef
131. Nanomedicines Targeting Glioma Stem Cells
     Arjun Sabu et al, 2022, ACS Appl. Mater. Interfaces CrossRef
132. TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma
     Lee Admoni-Elisha et al, 2022 CrossRef
133. Glioblastoma cell invasiveness and epithelial-to-mesenchymal transitioning are modulated by kinin receptors
     Mona N. Oliveira et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
134. The Role of microRNAs in Multidrug Resistance of Glioblastoma
     Parvaneh Mahinfar et al, 2022, Cancers CrossRef
135. Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma
     Rachael G. Aubin et al, 2022, Nat Commun CrossRef
136. Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
     Jason Thomas Duskey et al, 2022, Pharmaceutics CrossRef
137. A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models
     Negar Sadeghipour et al, 2022, Sci Rep CrossRef
138. Combining Bevacizumab with Knocked-Down β-Catenin Reduces VEGF-A and Slug mRNA in HepG2 but not in Caco-2 Cell Lines
     Reem Mebed et al, 2022, CMM CrossRef
139. Glioblastoma multiforme in patients with human immunodeficiency virus: an integrated review and analysis
     Mynor J. Mendez Valdez et al, 2022, J Neurooncol CrossRef
140. Glioblastoma hijacks neuronal mechanisms for brain invasion
     Varun Venkataramani et al, 2022, Cell CrossRef
141. The low affinity A2B adenosine receptor enhances migratory and invasive capacity in vitro and angiogenesis in vivo of glioblastoma stem-like cells
     José I. Erices et al, 2022, Front. Oncol. CrossRef
142. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT)
     Shengying Shi et al, 2022, European Journal of Pharmacology CrossRef
143. Suppressor of fused associates with dissemination patterns in patients with glioma
     María Peris-Celda et al, 2022, Front. Oncol. CrossRef
144. Substrate stiffness effect on molecular crosstalk of epithelial-mesenchymal transition mediators of human glioblastoma cells
     Bernadette Basilico et al, 2022, Front. Oncol. CrossRef
145. The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
     Xin Hu et al, 2022, iScience CrossRef
146. Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells
     Zuzana Majercikova et al, 2022, IJMS CrossRef
147. The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression
     Chungen Lan et al, 2022, Cell Death Dis CrossRef
148. Exploring the role of Nrf2 signaling in glioblastoma multiforme
     Wireko Andrew Awuah et al, 2022, Discov Onc CrossRef
149. Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension
     Agata Gozdz et al, 2022, Cancers CrossRef
150. Emerging trends and research foci of epithelial–mesenchymal transition in gliomas: A scientometric analysis and review
     Yang Xing et al, 2022, Front. Oncol. CrossRef
151. Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions
     Tianzhong Li et al, 2022, Journal of Controlled Release CrossRef
152. The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
     Lina Alhaddad et al, 2022, IJMS CrossRef
153. Association between high immune activity and worse prognosis in uveal melanoma and low-grade glioma in TCGA transcriptomic data
     Hitoshi Matsuo et al, 2022, BMC Genomics CrossRef
154. Periostin promotes EMT via inhibition of RIN1-mediated endocytosis of EGFR in gliomas
     Fengqi Zhou et al, 2022, Holist Integ Oncol CrossRef
155. Effect of Copper Chelators via the TGF-β Signaling Pathway on Glioblastoma Cell Invasion
     Heabin Kim et al, 2022, Molecules CrossRef
156. Immunostaining protocol for infiltrating brain cancer spheroids for light-sheet imaging
     Benedicte Bjørknes et al, 2023, PLoS ONE CrossRef
157. Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients
     Faisal A. Alzahrani et al, 2023, IJMS CrossRef
158. Periostin is Oncogenic and Promotes EMT in Gliomas via Inhibition of RIN1-Mediated Endocytosis of EGFR
     Fengqi Zhou et al, 2021, SSRN Journal CrossRef
159. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets
     José Ignacio Erices et al, 2023, IJMS CrossRef
160. Glycation Leads to Increased Invasion of Glioblastoma Cells
     Paola Schildhauer et al, 2023, Cells CrossRef
161. Identification of Prominent Genes between 3D Glioblastoma Models and Clinical Samples via GEO/TCGA/CGGA Data Analysis
     Brandon Wee Siang Phon et al, 2023, Biology CrossRef
162. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis
     Yanran Bi et al, 2023, Genes & Diseases CrossRef
163. Robust formation of optimal single spheroids towards cost‐effective in vitro three‐dimensional tumor models
     Kinana Habra et al, 2023, FEBS Open Bio CrossRef
164. Radiotherapy and radio‐sensitization in H3 K27M ‐mutated diffuse midline gliomas
     Chao Liu et al, 2023, CNS Neurosci Ther CrossRef
165. NAA10 overexpression dictates distinct epigenetic, genetic, and clinicopathological characteristics in adult gliomas
     Minh-Khang Le et al, 2023 CrossRef
166. Regulation of EMT Markers, Extracellular Matrix, and Associated Signalling Pathways by Long Non-Coding RNAs in Glioblastoma Mesenchymal Transition: A Scoping Review
     Dexter Hoi Long Leung et al, 2023, Biology CrossRef
167. Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
     Huiqun Huang et al, 2023, Pharmaceutics CrossRef
168. Surface Functionalization of Gold Nanoparticles for Targeting the Tumor Microenvironment to Improve Antitumor Efficiency
     Kin Fai Tan et al, 2023, ACS Appl. Bio Mater. CrossRef
169. The role and clinical relevance of long non-coding RNAs in glioma
     Ilgiz Gareev et al, 2023, Non-coding RNA Research CrossRef
170. Glioblastoma cell invasion: Go? Grow? Yes
     David J Odde, 2023 CrossRef
171. Photobac derived from bacteriochlorophyll-a shows potential for treating brain tumor in animal models by photodynamic therapy with desired pharmacokinetics and limited toxicity in rats and dogs
     Farukh A. Durrani et al, 2023, Biomedicine & Pharmacotherapy CrossRef
172. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
     Smita Kumari et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
173. Role of UBE2C in Brain Cancer Invasion and Dissemination
     Stefani Domentean et al, 2023, IJMS CrossRef
174. SOX8 promotes tumor growth and metastasis through FZD6-dependent Wnt/β-catenin signaling in colorectal carcinoma
     Chen Li et al, 2023, Heliyon CrossRef
175. Jagged1 intracellular domain/SMAD3 complex transcriptionally regulates TWIST1 to drive glioma invasion
     Jung Yun Kim et al, 2023, Cell Death Dis CrossRef
176. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
     Nasim Ebrahimi et al, 2024, Cancer Metastasis Rev CrossRef
177. Emerging Lipid Targets in Glioblastoma
     Ammar Darwish et al, 2024, Cancers CrossRef
178. Exploring the prospective of phytochemicals derived from Indian medicinal-plants for management and treatment of glioblastoma multiforme based on in-vitro studies
     Sunita Jhulki et al, 2024, Journal of Herbal Medicine CrossRef
179. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation
     Jin Zhang et al, 2023 CrossRef
180. KIF4A promotes epithelial–mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells
     Yao Xu et al, 2024, Mol Cell Biochem CrossRef
181. Ursolic acid inhibits glioblastoma through suppressing TGFβ-mediated epithelial-mesenchymal transition (EMT) and angiogenesis
     Bo Hei et al, 2024, Heliyon CrossRef
182. Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes
     Victor Chérouvrier Hansson et al, 2024, IJMS CrossRef
183. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt–β-catenin pathway
     Peng Yu et al, 2024, J Exp Clin Cancer Res CrossRef
184. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
     Pan Song et al, 2024, J Hematol Oncol CrossRef
185. EIF4A3-Induced Circ_0059914 Promoted Angiogenesis and EMT of Glioma via the miR-1249/VEGFA Pathway
     Wei Yu et al, 2024, Mol Neurobiol CrossRef
186. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.
     Souad Djediai et al, 2021, Int J Mol Sci CrossRef